XOLAIR

Google image searchProduct monograph

Active ingredient

omalizumab, 150 MG/1 ML

DIN: 02545144

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: PREFILLED PEN - SINGLE USE

Schedule: Prescription / Schedule D

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 25-SEP-2024

ATC:

• R03 — DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD, )
• R03D — OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES (ATC, ATC/DDD)
• R03DX — Other systemic drugs for obstructive airway diseases (ATC, ATC/DDD)
• R03DX05 — OMALIZUMAB (ATC/DDD)

Reference brand drug: Xolair

External Links for Xolair

Search on Google

• Xolair side effects
• Xolair dosage
• omalizumab side effects
• omalizumab dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find xolair photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.